We are live on ! Find out more
LOGC

LogicBio Therapeutics, Inc. Common Stock
LOGC

Delisted

LOGC was delisted on the 15th of November, 2022.

Back to rankings

47 hedge funds and large institutions have $917K invested in LogicBio Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

2% more funds holding

Funds holding: 46 → 47 (+1)

50% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 12

89% less capital invested

Capital invested by funds: $8.66M → $917K (-$7.75M)

Holders
47
Holders Change
+1
Holders Change %
+2.17%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
12
Closed
6
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
Prudential Financial
Prudential Financial
New Jersey
+$32.4K
2
Jane Street
Jane Street
New York
+$26K
3
IBOK
Independence Bank of Kentucky
Kentucky
+$16.2K
4
UBS Group
UBS Group
Switzerland
+$10.8K
5
TRCT
Tower Research Capital (TRC)
New York
+$4.82K

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$310K
2
Goldman Sachs
Goldman Sachs
New York
-$251K
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$159K
4
SCM
Sio Capital Management
New York
-$124K
5
VF
Virtu Financial
New York
-$49K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$1K -$159K -313,450 -99%
Barclays
27
Barclays
United Kingdom
$1K -$2.79K -5,525 -65%
LWANC
28
Laurel Wealth Advisors (North Carolina)
North Carolina
$1K – – –
US Bancorp
29
US Bancorp
Minnesota
$1K – – –
Citigroup
30
Citigroup
New York
$1K +$955 +1,888 New
FDCDDQ
31
Federation des caisses Desjardins du Quebec
Quebec, Canada
$315 – – –
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
$88 – – –
SCM
33
Sio Capital Management
New York
– -$124K -182,630 Closed
VF
34
Virtu Financial
New York
– -$49K -71,475 Closed
Millennium Management
35
Millennium Management
New York
– -$34K -50,285 Closed
Bank Julius Baer & Co
36
Bank Julius Baer & Co
Switzerland
– -$13K -19,450 Closed
HSBC Holdings
37
HSBC Holdings
United Kingdom
– -$8K -11,085 Closed
Osaic Holdings
38
Osaic Holdings
Arizona
– -$2.02K -4,000 -81%
Bank of America
39
Bank of America
North Carolina
– -$435 -861 -100%
Federated Hermes
40
Federated Hermes
Pennsylvania
– -$1K -526 Closed
Wells Fargo
41
Wells Fargo
California
– +$5 +10 +0.8%
Simplex Trading
42
Simplex Trading
Illinois
– +$20 +40 New
GI
43
Gradient Investments
Minnesota
– +$33 +65 New
Group One Trading
44
Group One Trading
Illinois
– +$51 +100 +9%
HR
45
Howe & Rusling
New York
– +$76 +150 New
1
2

LOGC Hedge Fund Activity: Q2 2022 in Review

47 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in LogicBio Therapeutics, Inc. Common Stock (LOGC) for Q2 2022, worth a combined $917K — down 89% from $8.66M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new LOGC positions and 6 closed out — a net gain of 1 holder — while 6 added to existing stakes and 12 trimmed.

The largest buyer was Prudential Financial, opening a new position worth an estimated $32.4K. The largest seller was Franklin Resources, cutting an estimated $310K.

  • 47 institutional investors held LogicBio Therapeutics, Inc. Common Stock (LOGC) as of Q2 2022, up from 46 in Q1 2022.
  • Funds reported $917K of LogicBio Therapeutics, Inc. Common Stock stock for Q2 2022, down 89% quarter-over-quarter.
  • 7 funds opened new LogicBio Therapeutics, Inc. Common Stock positions in Q2 2022 and 6 closed out, a net change of +1 holder.
  • The largest LogicBio Therapeutics, Inc. Common Stock buyer in Q2 2022 was Prudential Financial, an estimated $32.4K added.
  • The largest LogicBio Therapeutics, Inc. Common Stock seller in Q2 2022 was Franklin Resources, an estimated $310K sold.

Based on aggregated 13F filings for Q2 2022.